Biotech
-
-390x220.jpg)
NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients
[ad_1] NeuroRx is planning to maneuver NRX-101 into part 2b/3 after detecting indicators of efficacy in a feasibility trial in…
Read More » -
Biogen bails on AGTC after ocular gene therapy flunks trial
[ad_1] Applied Genetic Technologies’ $1 billion-plus gene therapy pact with Biogen has been torn up after their lead candidate failed…
Read More » -
Could a once-abandoned obesity drug be revived in osteoporosis?
[ad_1] Irisin, the as soon as much-hyped however controversial “exercise hormone” that researchers had hoped would be an efficient obesity…
Read More » -
Biofrontera cleared of wrongdoing in Nasdaq IPO
[ad_1] An impartial evaluation has cleared Biofrontera of wrongdoing associated to its U.S. IPO. Shareholders had accused Biofrontera of appearing…
Read More » -
FDA hails 2018 as bumper year for drug development successes
[ad_1] The FDA has hailed 2018 as a standout year for drug development and approvals, each by way of the…
Read More » -
Interactive Map Displays Strength of Industry’s National Footprint
[ad_1] BIO’s biennial financial growth and jobs report focuses on the financial progress and nationwide footprint of the bioscience business.…
Read More » -
GenSight rebuilds its case for LHON gene therapy, eyeing filing next year
[ad_1] GenSight Biologics has reported new knowledge from its section 3 program for GS010, its gene remedy for an ultrarare…
Read More » -
BIO Hosts Embassy Briefing on International Economic Development
[ad_1] Last week BIO hosted embassy representatives from over 25 international locations to debut a brand new report that highlights…
Read More » -
HEALTH FOUNDATION OF SOUTH FLORIDA NAMES NEW POLICY AND PUBLIC AFFAIRS DIRECTOR
[ad_1] Natalie Ok. Castellanos, JD MIAMI, FL, Dec. 11, 2018 (GLOBE NEWSWIRE) — Health Foundation of South Florida, the biggest…
Read More » -
National Research Corporation Declares Special and Quarterly Dividend Nasdaq:NRC
[ad_1] NRC Logo NRC brand National Research Corporation Lincoln, Nebraska, Dec. 10, 2018 (GLOBE NEWSWIRE) — image002National Research Corporation (NASDAQ:NRC)…
Read More »
